Social Contributions

Eczema Awareness and Support

More than two million Canadians have a chronic skin condition called atopic dermatitis (AD) or eczema. Moderate to severe forms of eczema can have a profound, life-altering impact on sufferers as well as their family or caregivers. Research conducted with eczema patients and caregivers from across Canada, along with input from a Medical Advisory Board, helped focus our attention on the importance of compliance as a key factor in managing eczema. A unique online program designed specifically for Protopic users is aimed at improving treatment outcomes by helping individuals follow their prescribed treatment plan.

The Eczema Awareness, Support and Education (EASE®) Program

The EASE Program was developed in collaboration with Canadian dermatologists to meet the need for comprehensive, non-commercial information on eczema. It has received the Canadian Dermatology Association’s Public Education Award many times.

Funded through an educational grant from Astellas, the EASE Program (www.eczemacanada.ca) operates nationally to provide educational materials, community outreach and online information to AD sufferers, as well as to support the counselling efforts of healthcare professionals. All materials are available in English and French, and the EASE Program handbook is also available in Mandarin, Punjabi and Vietnamese. One of the goals of the EASE Program is to help eczema sufferers better understand the chronic nature of this disease, its triggers, treatment options and psychosocial issues.

EASE Program

Penny’s World was created to help the youngest eczema sufferers learn about their condition through an animated book and website (www.pennysworld.ca) that features easy-to-grasp concepts and language, colourful illustrations and fun games.

Visit the EASE Program at www.eczemacanada.ca and Penny’s World at www.pennysworld.ca for more information.

Pennys World
Rx&ampD Member Health Products Stewardship Site Map | Privacy Policy | Legal Disclaimer | Contact Us
© 2011 Astellas Pharma Canada, Inc. All Rights Reserved.